PMID: 9545706Apr 18, 1998Paper

Pathogenesis and therapy of Hodgkin lymphoma

Medizinische Klinik
H TeschA Engert

Abstract

Although the pathogenesis of Hodgkin's disease is not clear, molecular analyses reveal characteristic features. EBV infection can be demonstrated in more than 50% of cases at the DNA or protein level. Recently, immunoglobulin gene rearrangements were found in single Hodgkin and Reed-Sternberg cells. Sequence analyses revealed that the rearranged Ig genes have frequently somatic mutations, which indicate that the cells are derived from the germinal center. These rearrangements may be used as defined markers to detect residual disease after chemotherapy. Modern polychemotherapy regimen and radiotherapy are very effective, and 60-90% of patients, depending on stage of the disease and risk factors, can be cured. Salvage therapy for relapsed patients including high-dose chemotherapy with autologous stem cell support frequently results in remission although duration is frequently short. New immunotherapy strategies with immunotoxins or bispecific antibodies are currently analysed in clinical studies.

References

Sep 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E D KreuserE Thiel
Sep 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S PoppemaL Visser
Nov 19, 1992·The New England Journal of Medicine·G P CanellosB A Peterson
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M CossetM Tubiana
Sep 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ValagussaG Bonadonna
Sep 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Henry-Amar
Jan 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S VivianiG Bonadonna
Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Dec 1, 1991·The American Journal of Medicine·J O ArmitageD T Purtilo
Oct 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D E ReeceC F LeMaistre
Feb 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P MauchM Jochelson
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J JonesS D Rowley
Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M CarellaP Coser
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J HorningS A Rosenberg
Feb 23, 1989·The New England Journal of Medicine·L M WeissJ Sklar
Mar 16, 1989·The New England Journal of Medicine·N MuellerJ Vogelman
Nov 16, 1988·Journal of the National Cancer Institute·S PavlovskyO Magnasco
Feb 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ZittounJ Diebold
Sep 15, 1971·International Journal of Cancer. Journal International Du Cancer·P Correa, G T O'Conor
Mar 1, 1982·Cancer Treatment Reviews·G Bonadonna, A Santoro
Jan 15, 1981·The New England Journal of Medicine·N Gutensohn, P Cole
Jan 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E M NoordijkN Dupouy
Oct 5, 1995·The New England Journal of Medicine·M HummelH Stein
Jan 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Wolf, V Diehl
Nov 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P J BiermanJ O Armitage
Jul 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J O Armitage
Jan 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F HartmannM Pfreundschuh
Aug 14, 1997·The New England Journal of Medicine·A JoxJ Wolf

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
R KüppersA Josting
Annals of Oncology : Official Journal of the European Society for Medical Oncology
R SchnellA Engert
© 2022 Meta ULC. All rights reserved